Jinshiya Medicine: Director Lin Qiang plans to reduce 0.39% of the company's shares.

Jinshiya Pharmaceutical Co., Ltd. announced that Lin Qiang, a director, vice president, and secretary of the board of directors, plans to reduce his holdings by no more than 1.5662 million shares, representing 0.39% of the total share capital of the company, through centralized bidding or block trading within three months after the announcement of the reduction plan, starting from the fifteenth trading day. Lin Qiang currently holds 6.2649 million shares of the company, accounting for 1.56% of the total share capital. The reason for the reduction is for personal financial needs. The reduction period is from July 11, 2025, to October 10, 2025, and the reduction price will be determined based on market prices and trading methods.